| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.22M | 38.60M | 32.64M | 21.37M | 24.46M | 22.79M |
| Gross Profit | 23.84M | 23.89M | 17.21M | 12.26M | 12.40M | 13.95M |
| EBITDA | 5.95M | 8.27M | 6.05M | 3.02M | 2.48M | 3.75M |
| Net Income | 3.99M | 6.38M | 4.04M | 2.12M | 1.70M | 2.77M |
Balance Sheet | ||||||
| Total Assets | 47.81M | 56.63M | 58.74M | 39.74M | 53.89M | 41.85M |
| Cash, Cash Equivalents and Short-Term Investments | 27.25M | 31.48M | 30.72M | 17.16M | 11.43M | 14.24M |
| Total Debt | 1.09M | 1.24M | 1.08M | 221.00K | 200.00K | 277.00K |
| Total Liabilities | 9.41M | 14.11M | 29.24M | 12.40M | 22.00M | 10.97M |
| Stockholders Equity | 38.40M | 42.52M | 29.50M | 27.34M | 31.89M | 30.89M |
Cash Flow | ||||||
| Free Cash Flow | 1.66M | -9.99M | 15.34M | 13.52M | -1.10M | 3.10M |
| Operating Cash Flow | 1.71M | -9.11M | 16.11M | 14.04M | -659.00K | 3.33M |
| Investing Cash Flow | 3.16M | 4.20M | -164.00K | -517.00K | -639.00K | -229.00K |
| Financing Cash Flow | -3.47M | -2.33M | -2.38M | -7.80M | -1.51M | -1.63M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £105.60M | 14.39 | 5.57% | ― | -1.34% | 20.88% | |
68 Neutral | £142.73M | 1,385.77 | 0.31% | ― | -1.56% | -98.71% | |
68 Neutral | £203.01M | 82.94 | 5.22% | 0.80% | 19.00% | -53.85% | |
67 Neutral | £134.64M | 14.71 | 8.80% | 1.68% | 3.82% | -18.43% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | £439.45M | -5.94 | -14.39% | 1.73% | 0.82% | -997.08% | |
54 Neutral | £30.02M | 10.41 | 8.83% | 2.44% | -25.62% | -20.46% |